Recombinant erythropoietin in the treatment of anemia in cancer patients

This article reviews the role of recombinant erythropoietin in the management of anemia in cancer patients based on literature data and our experience. We describe the problem of toxicity and report clinical recommendations and cautions for usage of drugs appertain to this pharmaceutical group.

Saved in:
Bibliographic Details
Main Authors: S. V. Vorobiova, T. Z. Cherniavskaya, S. G. Pushkareva, G. P. Frolov, K. N. Melkova
Format: Article
Language:Russian
Published: ABV-press 2022-11-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/684
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849241219872325632
author S. V. Vorobiova
T. Z. Cherniavskaya
S. G. Pushkareva
G. P. Frolov
K. N. Melkova
author_facet S. V. Vorobiova
T. Z. Cherniavskaya
S. G. Pushkareva
G. P. Frolov
K. N. Melkova
author_sort S. V. Vorobiova
collection DOAJ
description This article reviews the role of recombinant erythropoietin in the management of anemia in cancer patients based on literature data and our experience. We describe the problem of toxicity and report clinical recommendations and cautions for usage of drugs appertain to this pharmaceutical group.
format Article
id doaj-art-9892bdef0d484eeda9c2f49abb0f7675
institution Kabale University
issn 1818-8346
2413-4023
language Russian
publishDate 2022-11-01
publisher ABV-press
record_format Article
series Онкогематология
spelling doaj-art-9892bdef0d484eeda9c2f49abb0f76752025-08-20T04:00:14ZrusABV-pressОнкогематология1818-83462413-40232022-11-0103768010.17650/1818-8346-2007-0-3-76-80562Recombinant erythropoietin in the treatment of anemia in cancer patientsS. V. Vorobiova0T. Z. Cherniavskaya1S. G. Pushkareva2G. P. Frolov3K. N. Melkova4N.N. Blokhin Cancer Research CenteN.N. Blokhin Cancer Research CenteState Research Center –Institute of biophysicsState Research Center –Institute of biophysicsN.N. Blokhin Cancer Research CenteThis article reviews the role of recombinant erythropoietin in the management of anemia in cancer patients based on literature data and our experience. We describe the problem of toxicity and report clinical recommendations and cautions for usage of drugs appertain to this pharmaceutical group.https://oncohematology.abvpress.ru/ongm/article/view/684anemiaerythropoietinr-hueporecommendationscomplicationsvero-epoetin
spellingShingle S. V. Vorobiova
T. Z. Cherniavskaya
S. G. Pushkareva
G. P. Frolov
K. N. Melkova
Recombinant erythropoietin in the treatment of anemia in cancer patients
Онкогематология
anemia
erythropoietin
r-huepo
recommendations
complications
vero-epoetin
title Recombinant erythropoietin in the treatment of anemia in cancer patients
title_full Recombinant erythropoietin in the treatment of anemia in cancer patients
title_fullStr Recombinant erythropoietin in the treatment of anemia in cancer patients
title_full_unstemmed Recombinant erythropoietin in the treatment of anemia in cancer patients
title_short Recombinant erythropoietin in the treatment of anemia in cancer patients
title_sort recombinant erythropoietin in the treatment of anemia in cancer patients
topic anemia
erythropoietin
r-huepo
recommendations
complications
vero-epoetin
url https://oncohematology.abvpress.ru/ongm/article/view/684
work_keys_str_mv AT svvorobiova recombinanterythropoietininthetreatmentofanemiaincancerpatients
AT tzcherniavskaya recombinanterythropoietininthetreatmentofanemiaincancerpatients
AT sgpushkareva recombinanterythropoietininthetreatmentofanemiaincancerpatients
AT gpfrolov recombinanterythropoietininthetreatmentofanemiaincancerpatients
AT knmelkova recombinanterythropoietininthetreatmentofanemiaincancerpatients